查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1701297

连续生物加工市场规模、份额、趋势分析报告：按产品、应用、最终用途、地区、细分市场预测，2025-2030 年

Continuous Bioprocessing Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Reagents), By Application (Monoclonal Antibodies, Vaccines), By End Use, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

持续生物加工市场的成长与趋势：

根据Grand View Research, Inc.的最新报告，全球连续生物加工市场规模预计到2030年将达到9.1143亿美元，2025年至2030年期间的复合年增长率为18.63%。

持续生物加工市场受到对生技药品、生物相似药、细胞和基因疗法以及单株抗体（mAb）等先进疗法日益增长的需求的推动。随着製药和生技公司寻求更高的效率、更低的成本和更快的生产週期，连续生物加工正在成为关键的解决方案。与传统的批量处理相比，连续生物处理具有更高的生产率、更大的扩充性和改进的製程控制，使其成为大规模生技药品生产的必需品。此外，一次性生物反应器、基于灌注的系统和製程分析技术 (PAT) 的进步正在加速各行业采用连续生物加工。

由于对快速疫苗生产、可扩展製造和高效供应链的需求日益增长，COVID-19 疫情成为采用连续生物加工的主要催化剂。开发 mRNA 疫苗、单株抗体和抗病毒疗法的公司已转向连续生物加工以满足全球需求，同时维持较高的产品品质。此次疫情也凸显了传统批次製程的脆弱性，导致对灵活、扩充性和自动化的连续生物製造解决方案的投资增加。因此，疫情过后，许多生物製药公司将继续投资连续生物加工技术，以确保全球生物製造业的长期市场成长和弹性。

生物製药公司、CMO 和监管机构之间日益加强的合作也在推动市场成长。 FDA 和 EMA 等监管机构正在透过提供指导方针、奖励和更快的核准途径积极支持向连续生产的转变。此外，主要企业正在大力投资自动化、人工智慧主导的流程监控和即时分析，以进一步优化製造工作流程。连续层析法、线上品管和模组化生物反应器系统的整合简化了生技药品的生产，减少了差异性并确保了产品品质的一致性。

连续生物加工市场报告重点

  • 按产品划分，消耗品和试剂将在 2024 年占据市场主导地位。从传统批量处理到连续生物处理的转变推动了对连续生物处理的消耗品和试剂的需求不断增长。
  • 根据应用，单株抗体部分将占据市场主导地位，到 2024 年将占据 29.98% 的最大收入份额。随着製造商寻求降低生产成本，同时保持高产品纯度和效力，向生物仿製药的转变和对製程强化的监管支持将进一步推动采用。
  • 根据最终用途，製药和生物技术公司将主导市场，到 2024 年将占据最大的收益占有率，达到 48.43%。 FDA 和 EMA 等机构对持续製造和製程改进的监管支持进一步鼓励生物製药公司投资下一代生物製程解决方案。
  • 2024年，北美将引领市场，占据最大的收益占有率，为37.46%。这一优势源于对生物製药研发的大量投资、完善的製造基础设施以及支持先进生物加工技术的优惠监管政策。

目录

第一章调查方法与范围

第二章执行摘要

3. 连续生物加工市场变数与趋势

  • 市场展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 驱动程式
    • 限制因素
  • 产业分析工具
    • 产业分析-波特五力分析
    • PESTEL分析
    • COVID-19影响分析

第四章 连续生物加工：产品估算与趋势分析

  • 产品细分仪表板
  • 连续生物加工市场：产品变异性分析
  • 连续生物加工市场规模与趋势分析（按产品）（2018-2030）
  • 装置
    • 2018年至2030年设备市场估计与预测
    • 生物反应器
    • 过滤系统
    • 层析法系统
    • 过程分析技术
    • 其他的
  • 耗材和试剂
    • 2018年至2030年消耗品和试剂市场估计和预测
    • 培养基和缓衝液
    • 过滤器和薄膜
    • 树脂
    • 管和袋
    • 其他的

第五章连续生物加工：应用评估与趋势分析

  • 应用程式细分仪表板
  • 连续生物加工市场：应用趋势分析
  • 连续生物加工市场规模及应用趋势分析（2018-2030）
  • 单株抗体
  • 疫苗
  • 细胞和基因治疗
  • 研究与开发
  • 其他用途

第六章连续生物加工：最终用途估算与趋势分析

  • 最终用途细分仪表板
  • 连续生物加工市场：最终用途差异分析
  • 连续生物加工市场规模和趋势分析（按最终用途）（2018-2030 年）
  • 製药和生物技术公司
  • CMO和CRO
  • 研究和学术机构

第七章连续生物加工：区域估计与趋势分析

  • 区域市场仪表板
  • 2024 年及 2030 年区域市场占有率分析
  • 各地区连续生物加工市场：关键要点
  • 北美洲
    • 2018-2030年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2018-2030年欧洲市场估计与预测
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麦
  • 亚太地区
    • 2018-2030年亚太市场估计与预测
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 2018-2030年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 2018-2030年中东和非洲市场估计和预测
    • 沙乌地阿拉伯
    • 南非
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 参与企业分类
  • 2024年企业市场分析
  • 参与企业概况
    • Danaher
    • Sartorius AG
    • Thermo Fisher Scientific Inc.
    • WuXi Biologics
    • Ginkgo Bioworks
    • Merck KGaA
    • GE Healthcare
    • Repligen Corporation
    • Asahi Kasei Bioprocess America, Inc.
Product Code: GVR-4-68040-535-2

Continuous Bioprocessing Market Growth & Trends:

The global continuous bioprocessing market size is anticipated to reach USD 911.43 million by 2030, growing at a CAGR of 18.63% from 2025 to 2030, according to a new report by Grand View Research, Inc. The continuous bioprocessing market is driven by the increasing demand for biologics, biosimilars, and advanced therapies such as cell and gene therapies and monoclonal antibodies (mAbs). As pharmaceutical and biotechnology companies seek higher efficiency, reduced costs, and faster production cycles, continuous bioprocessing has emerged as a key solution. Compared to traditional batch processing, continuous bioprocessing offers higher productivity, better scalability, and improved process control, making it essential for large-scale biologics manufacturing. Additionally, advancements in single-use bioreactors, perfusion-based systems, and process analytical technologies (PAT) are accelerating the adoption of continuous bioprocessing across the industry.

The COVID-19 pandemic acted as a major catalyst for the adoption of continuous bioprocessing, as the need for rapid vaccine production, scalable manufacturing, and efficient supply chains intensified. Companies developing mRNA vaccines, monoclonal antibodies, and antiviral therapies turned to continuous bioprocessing to meet global demand while maintaining high product quality. The pandemic also highlighted vulnerabilities in traditional batch processing, leading to increased investments in flexible, scalable, and automated continuous biomanufacturing solutions. As a result, post-pandemic, many biopharma companies have continued to invest in continuous bioprocessing technologies, ensuring long-term market growth and resilience in global biomanufacturing.

The increasing collaboration between biopharma companies, CMOs, and regulatory agencies is also driving market growth. Regulatory bodies such as the FDA and EMA have been actively supporting the shift towards continuous manufacturing by providing guidelines, incentives, and faster approval pathways. Moreover, key players are investing heavily in automation, AI-driven process monitoring, and real-time analytics, further optimizing production workflows. The integration of continuous chromatography, inline quality control, and modular bioreactor systems is streamlining biologics manufacturing, reducing variability, and ensuring consistent product quality.

Continuous Bioprocessing Market Report Highlights:

  • Based on product, consumables & reagents dominated the market in 2024. The shift from traditional batch processing to continuous bioprocessing has led to a growing demand for continuous bioprocessing consumables& reagents
  • Based on application, the monoclonal antibodies segment dominated the market, with the largest revenue share of 29.98% in 2024. The shift toward biosimilars and regulatory support for process intensification further fuel adoption, as manufacturers seek to reduce production costs while maintaining high product purity and potency
  • Based on end use, pharmaceutical and biotechnology companies dominated the market, with the largest revenue share of 48.43% in 2024. The regulatory support from agencies like the FDA and EMA for continuous manufacturing and process intensification is further encouraging biopharma firms to invest in next-generation bioprocessing solutions
  • In 2024, North America led the market, accounting for the largest revenue share of 37.46%. This dominance is fueled by significant investments in biopharmaceutical R&D, a well-established manufacturing infrastructure, and favorable regulatory policies supporting advanced bioprocessing technologies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End Use
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Continuous bioprocessing market Variables and Trends

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Growing Demand for Biologics & Biosimilars
      • 3.2.1.2. Technological Advancements & Single-Use Systems
    • 3.2.2. Restraints
      • 3.2.2.1. High Initial Investment & Process Complexity
  • 3.3. Industry Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Continuous Bioprocessing: Product Estimates & Trend Analysis

  • 4.1. Product Segment Dashboard
  • 4.2. Continuous bioprocessing market: Product Movement Analysis
  • 4.3. Continuous bioprocessing market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Bioreactors
      • 4.4.2.1. Bioreactors market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Filtration Systems
      • 4.4.3.1. Filtration systems market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Chromatography Systems
      • 4.4.4.1. Chromatography systems market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.5. Process Analytical Technologies
      • 4.4.5.1. Process analytical technologies market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.6. Others
      • 4.4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Consumables & Reagents
    • 4.5.1. Consumables & reagents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Media & Buffers
      • 4.5.2.1. Media & buffers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Filters & Membranes
      • 4.5.3.1. Filters & membranes market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Resin
      • 4.5.4.1. Resin market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Tubing & Bags
      • 4.5.5.1. Tubing & bags market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.6. Other
      • 4.5.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Continuous Bioprocessing: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. Continuous bioprocessing market: Application Movement Analysis
  • 5.3. Continuous bioprocessing market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Monoclonal antibodies
    • 5.4.1. Monoclonal antibodies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Vaccines
    • 5.5.1. Vaccines market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Cell and gene therapy
    • 5.6.1. Cell and gene therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Research & Development
    • 5.7.1. Research & development market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Other Applications
    • 5.8.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Continuous Bioprocessing: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Continuous bioprocessing market: End Use Movement Analysis
  • 6.3. Continuous bioprocessing market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. CMOs and CROs
    • 6.5.1. CMOs and CROs market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Research and Academic Institutes
    • 6.6.1. Research and academic institutes market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Continuous Bioprocessing: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Continuous bioprocessing market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Competitive Scenario
      • 7.4.2.3. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Competitive Scenario
      • 7.4.3.3. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Mexico
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Competitive Scenario
      • 7.4.4.3. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Europe
    • 7.5.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Competitive Scenario
      • 7.5.2.3. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Competitive Scenario
      • 7.5.3.3. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. France
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Competitive Scenario
      • 7.5.4.3. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Competitive Scenario
      • 7.5.5.3. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Competitive Scenario
      • 7.5.6.3. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Competitive Scenario
      • 7.5.7.3. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Competitive Scenario
      • 7.5.8.3. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Key Country Dynamics
      • 7.5.9.2. Competitive Scenario
      • 7.5.9.3. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Competitive Scenario
      • 7.6.2.3. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. China
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Competitive Scenario
      • 7.6.3.3. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.4. India
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Competitive Scenario
      • 7.6.4.3. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Competitive Scenario
      • 7.6.5.3. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Competitive Scenario
      • 7.6.6.3. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.7. South Korea
      • 7.6.7.1. Key Country Dynamics
      • 7.6.7.2. Competitive Scenario
      • 7.6.7.3. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. Latin America
    • 7.7.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Competitive Scenario
      • 7.7.2.3. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. Argentina
      • 7.7.3.1. Key Country Dynamics
      • 7.7.3.2. Competitive Scenario
      • 7.7.3.3. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.8. MEA
    • 7.8.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Competitive Scenario
      • 7.8.2.3. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.3. South Africa
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Competitive Scenario
      • 7.8.3.3. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Competitive Scenario
      • 7.8.4.3. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Key Country Dynamics
      • 7.8.5.2. Competitive Scenario
      • 7.8.5.3. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Participant Categorization
  • 8.2. Company Market Position Analysis, 2024
  • 8.3. Participant Overview
    • 8.3.1. Danaher
      • 8.3.1.1. Company overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. Sartorius AG
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Thermo Fisher Scientific Inc.
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. WuXi Biologics
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Ginkgo Bioworks
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Merck KGaA
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. GE Healthcare
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Repligen Corporation
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Asahi Kasei Bioprocess America, Inc.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 Global Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 3 Global Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 4 Global Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 5 Global Continuous bioprocessing market, by region, 2018 - 2030 (USD Million)
  • Table 6 North America Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 7 North America Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 8 North America Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 9 North America Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 10 U.S. Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 11 U.S. Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 14 Canada Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 15 Canada Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Mexico Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Mexico Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 20 Europe Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 21 Europe Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 22 Europe Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Germany Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 24 Germany Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 25 Germany Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 26 UK Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 27 UK Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 28 UK Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 29 France Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 30 France Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 31 France Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 33 Italy Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 34 Italy Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 36 Spain Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 37 Spain Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Sweden Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 39 Sweden Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 40 Sweden Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 41 Norway Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 42 Norway Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 43 Norway Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Denmark Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 45 Denmark Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Denmark Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 51 China Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 52 China Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 53 China Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 54 Japan Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 55 Japan Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 56 Japan Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 57 India Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 58 India Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 59 India Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 61 Australia Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 62 Australia Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 63 Thailand Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 64 Thailand Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 65 Thailand Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 66 South Korea Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 67 South Korea Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 68 South Korea Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 70 Latin America Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Latin America Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Latin America Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 73 Brazil Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 74 Brazil Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 75 Brazil Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 77 Argentina Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East and Africa Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 80 Middle East and Africa Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 81 Middle East and Africa Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Middle East and Africa Continuous bioprocessing market, by country, 2018 - 2030 (USD Million)
  • Table 83 South Africa Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Africa Continuous bioprocessing market, by automation type, 2018 - 2030 (USD Million)
  • Table 85 South Africa Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Africa Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 89 Saudi Arabia Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 90 UAE Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 91 UAE Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 92 UAE Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Continuous bioprocessing market, by product, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Continuous bioprocessing market, by application, 2018 - 2030 (USD Million)
  • Table 95 Kuwait Continuous bioprocessing market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Continuous Bioprocessing: market outlook
  • Fig. 9 Continuous Bioprocessing competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Industry value chain analysis
  • Fig. 13 Continuous bioprocessing market driver impact
  • Fig. 14 Continuous bioprocessing market restraint impact
  • Fig. 15 Continuous bioprocessing market: Product movement analysis
  • Fig. 16 Continuous bioprocessing market: Product outlook and key takeaways
  • Fig. 17 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Filtration systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Chromatography systems market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Process analytical technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Consumables & reagents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Media & buffers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Filters & membranes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Resin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Tubing & Bags market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Continuous bioprocessing market: Application movement analysis
  • Fig. 30 Continuous bioprocessing market: Application outlook and key takeaways
  • Fig. 31 Monoclonal antibodies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Vaccines market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Cell and gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Research & Development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Other Applications market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Continuous bioprocessing market: End use movement analysis
  • Fig. 37 Continuous bioprocessing market: End use outlook and key takeaways
  • Fig. 38 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 CMOs and CROs market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Research and academic institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Global Continuous bioprocessing market: Regional movement analysis
  • Fig. 42 Global Continuous bioprocessing market: Regional outlook and key takeaways
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)